This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Opexa Therapeutics Inc (OPXA)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 23.64M 592.00K 7.11M 3.81M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 1.12M 1.08M 124.77K 85.52K
Total Current Assets 24.77M 1.67M 7.23M 3.90M
Property, Plant & Equipment, Gross 3.01M 2.76M 2.22M 1.93M
Accumulated Depreciation & Depletion 1.72M 1.49M 1.19M 1.11M
Property, Plant & Equipment, Net 1.30M 1.27M 1.03M 815.96K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 177.67K 1.21M 0.00 0.00
Total Non-Current Assets 1.47M 2.48M 1.03M 815.96K
Liabilities & Shareholder Equity
Total Assets 26.24M 4.15M 8.26M 4.71M
Accounts Payable 696.16K 412.10K 491.32K 373.84K
Short Term Debt 0.00 0.00 0.00 35.61K
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 3.32M 885.98K 1.07M 745.30K
Long Term Debt 0.00 376.76K 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 2.34M 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 2.34M 376.76K 0.00 0.00
Total Liabilities 5.66M 1.26M 1.07M 745.30K
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 20.58M 2.88M 7.20M 3.97M
Common Par 275.46K 62.49K 230.48K 184.67K
Additional Paid In Capital 146.57M 112.43M 107.65M 98.50M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -126.27M -109.61M -100.68M -94.71M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 20.58M 3.26M 7.20M 3.97M
Total Equity 20.58M 2.88M 7.20M 3.97M
Total Liabilities & Stock Equity 26.24M 4.15M 8.26M 4.71M
Total Common Shares Outstanding 27.55M 6.25M 5.76M 4.62M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 13.33M 5.79M 5.63M 4.27M
Diluted Weighted Shares Outstanding 13.33M 5.79M 5.63M 4.27M
Number of Employees 38 26 19 11
Number of Part-Time Employees 0 0 0 0
OPXA News

OPXA Opexa Therapeutics Inc

Analysts Ratings for OPXA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET OPXA ANALYST REPORT

Brokerage Partners

OPXA Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs